Spinal Muscular Atrophy (SMA) Infographic

Patrick J. Rudewicz, Global Discovery Chemistry

Novartis and AveXis combine, aiming to transform the care of SMA, the #1 genetic cause of infant mortality. 

Usage Rights & Restrictions

This media asset is free for editorial broadcast, print, online and radio use. It is restricted for other purposes.

Download (PDF 466.01 KB)